1 Lee AL, "The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis : a randomised controlled trial" 15 : 44-, 2014
2 Goeminne PC, "The economic burden of bronchiectasis: known and unknown. A systematic review" 19 : 54-, 2019
3 Odnoletkova I, "The burden of common variable immunodeficiency disorders : a retrospective analysis of the European Society for Immunodeficiency(ESID)registry data" 13 : 201-, 2018
4 Al-Jahdali H, "The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis" 12 : 135-161, 2017
5 Martinez-Garcia MA, "Spanish guidelines on treatment of bronchiectasis in adults" 54 : 88-98, 2018
6 Martinez-Garcia MA, "Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults" 54 : 79-87, 2018
7 Hill AT, "Pulmonary exacerbation in adults with bronchiectasis : a consensus definition for clinical research" 49 : 1700051-, 2017
8 임정우, "Prevalence of Primary Immunodeficiency in Korea" 대한의학회 27 (27): 788-793, 2012
9 Choi H, "Population-based prevalence of bronchiectasis and associated comorbidities in South Korea" 54 : 1900194-, 2019
10 White L, "Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis" 106 : 356-360, 2012
1 Lee AL, "The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis : a randomised controlled trial" 15 : 44-, 2014
2 Goeminne PC, "The economic burden of bronchiectasis: known and unknown. A systematic review" 19 : 54-, 2019
3 Odnoletkova I, "The burden of common variable immunodeficiency disorders : a retrospective analysis of the European Society for Immunodeficiency(ESID)registry data" 13 : 201-, 2018
4 Al-Jahdali H, "The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis" 12 : 135-161, 2017
5 Martinez-Garcia MA, "Spanish guidelines on treatment of bronchiectasis in adults" 54 : 88-98, 2018
6 Martinez-Garcia MA, "Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults" 54 : 79-87, 2018
7 Hill AT, "Pulmonary exacerbation in adults with bronchiectasis : a consensus definition for clinical research" 49 : 1700051-, 2017
8 임정우, "Prevalence of Primary Immunodeficiency in Korea" 대한의학회 27 (27): 788-793, 2012
9 Choi H, "Population-based prevalence of bronchiectasis and associated comorbidities in South Korea" 54 : 1900194-, 2019
10 White L, "Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis" 106 : 356-360, 2012
11 Chalmers JD, "New insights into the epidemiology of bronchiectasis" 154 : 1272-1273, 2018
12 Visser SK, "Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?" 197 : 803-810, 2019
13 Ringshausen FC, "Increasing bronchiectasis prevalence in Germany, 2009-2017 : a population-based cohort study" 54 : 1900499-, 2019
14 Denning DW, "Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults" 51 : 361-370, 2013
15 Park J, "Factors associated with radiologic progression of non-cystic fibrosis bronchiectasis during long-term follow-up" 21 : 1049-1054, 2016
16 Polverino E, "European Respiratory Society guidelines for the management of adult bronchiectasis" 50 : 1700629-, 2017
17 Huang HY, "Etiology and characteristics of patients with bronchiectasis in Taiwan : a cohort study from 2002 to 2016" 20 : 45-, 2020
18 Orriols R, "Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis" 90 : 299-305, 2015
19 Lee H, "Epidemiology of nontuberculous mycobacterial infection, South Korea, 2007-2016" 25 : 569-572, 2019
20 Prevots DR, "Epidemiology of human pulmonary infection with nontuberculous mycobacteria : a review" 36 : 13-34, 2015
21 Zanini A, "Effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis : a retrospective analysis of clinical and functional predictors of efficacy" 89 : 525-533, 2015
22 de la Rosa Carrillo D, "Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis" 96 : 406-416, 2018
23 King PT, "Characterisation of the onset and presenting clinical features of adult bronchiectasis" 100 : 2183-2189, 2006
24 Dhar R, "Bronchiectasis in India : results from the European Multicentre Bronchiectasis Audit and Research Collaboration(EMBARC)and Respiratory Research Network of India Registry" 7 : e1269-e1279, 2019
25 Chalmers JD, "Bronchiectasis : new therapies and new perspectives" 6 : 715-726, 2018
26 Barker AF, "Bronchiectasis" 346 : 1383-1393, 2002
27 Hill AT, "British Thoracic Society guideline for bronchiectasis in adults" 74 (74): 1-69, 2019
28 Pasteur MC, "An investigation into causative factors in patients with bronchiectasis" 162 (162): 1277-1284, 2000
29 Kadowaki T, "An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis" 53 : 37-44, 2015
30 Gao YH, "Aetiology of bronchiectasis in adults : a systematic literature review" 21 : 1376-1383, 2016
31 Guan WJ, "Aetiology of bronchiectasis in Guangzhou, southern China" 20 : 739-748, 2015
32 Shoemark A, "Aetiology in adult patients with bronchiectasis" 101 : 1163-1170, 2007
33 Aksamit TR, "Adult patients with bronchiectasis : a first look at the US Bronchiectasis Research Registry" 151 : 982-992, 2017